K Mori

Summary

Affiliation: National Institute of Infectious Diseases
Country: Japan

Publications

  1. pmc Suppression of acute viremia by short-term postexposure prophylaxis of simian/human immunodeficiency virus SHIV-RT-infected monkeys with a novel reverse transcriptase inhibitor (GW420867) allows for development of potent antiviral immune responses resulti
    K Mori
    AIDS Research Center, National Institute of Infectious Diseases, Tokyo Japan
    J Virol 74:5747-53. 2000
  2. ncbi request reprint Induction of protective immunity against pathogenic simian immunodeficiency virus by a foreign receptor-dependent replication of an engineered avirulent virus
    T Matano
    AIDS Research Center, National Institute of Infectious Diseases, 4 7 1 Gakuen, Musashi Murayama, 208 0011, Tokyo, Japan
    Vaccine 18:3310-8. 2000
  3. pmc Quintuple deglycosylation mutant of simian immunodeficiency virus SIVmac239 in rhesus macaques: robust primary replication, tightly contained chronic infection, and elicitation of potent immunity against the parental wild-type strain
    K Mori
    AIDS Research Center, National Institute of Infectious Diseases, Tokyo 162-8640, Japan
    J Virol 75:4023-8. 2001

Collaborators

Detail Information

Publications3

  1. pmc Suppression of acute viremia by short-term postexposure prophylaxis of simian/human immunodeficiency virus SHIV-RT-infected monkeys with a novel reverse transcriptase inhibitor (GW420867) allows for development of potent antiviral immune responses resulti
    K Mori
    AIDS Research Center, National Institute of Infectious Diseases, Tokyo Japan
    J Virol 74:5747-53. 2000
    ..This model provides a unique means to define mechanisms and correlates of disease protection...
  2. ncbi request reprint Induction of protective immunity against pathogenic simian immunodeficiency virus by a foreign receptor-dependent replication of an engineered avirulent virus
    T Matano
    AIDS Research Center, National Institute of Infectious Diseases, 4 7 1 Gakuen, Musashi Murayama, 208 0011, Tokyo, Japan
    Vaccine 18:3310-8. 2000
    ..This strategy may be useful for development of safe and effective vaccines against various kinds of pathogenic viruses...
  3. pmc Quintuple deglycosylation mutant of simian immunodeficiency virus SIVmac239 in rhesus macaques: robust primary replication, tightly contained chronic infection, and elicitation of potent immunity against the parental wild-type strain
    K Mori
    AIDS Research Center, National Institute of Infectious Diseases, Tokyo 162-8640, Japan
    J Virol 75:4023-8. 2001
    ..Thus, the quintuple deglycosylation mutant appeared to represent a novel class of SIV live attenuated vaccine...